Carcinoembryonic antigen and albumin predict survival in, patients with advanced colon and rectal cancer
Carcinoembryonic antigen and albumin predict survival in, patients with advanced colon and rectal cancer
复制标题
DOI:
10.1001/archsurg.138.9.962
复制
发表时间:
2003-09-01
影响因子:
--
通讯作者:
Stamos, MJ
中科院分区:
文献类型:
--
作者:
Dixon, MR;Haukoos, JS;Stamos, MJ
Hypothesis: Patients with stage IV colon or rectal cancer at initial diagnosis have characteristics that will predict subsequent survival time.Design: Retrospective cohort studySetting: Urban county teaching hospital providing tertiary care. Patients: Patients who came to the study institution with stage IV colon or rectal cancer between 1991-1999.Main Outcome Measure: Survival duration (days) after diagnosis.Results: One hundred five patients were identified, with a median survival of 225 days (interquartile, range, 72688 days). Univariate analysis identified carcinoembryonic antigen (CEA) and albumin (ALB) as possible predictors for survival. Classification and regression tree analysis, a form of binary recursive partitioning, was used to identify optimal cut points for CEA (275 ng/mL) and ALB (2.7 g/dL) levels. Based on the cut points, patients were stratified into the following groups: (1) low CEA, high ALB; (2) low CEA, low ALB; (3) high CEA, high ALB; and (4) high CEA, low ALB. The median survival times for the first group and the fourth group were 287 days (interquartile range, 150-851 days) and 39 days (interquartile range, 14-168 days), respectively. A Kaplan-Meier analysis was performed, and a statistically significant difference was identified across all strata (P = .004). Additionally, groups I and 4 demonstrated the largest overall survival difference (P